3 completed, 1 recruiting, 1 terminated, 1 unknown. 6 Phase 2, 2 Phase 3, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 6 | Completed 3, Recruiting 1, Terminated 1, Unknown 1 |
| Phase 3 | 2 | Completed 1, Unknown 1 |
| Phase 1 | 1 | Terminated 1 |
Follow Helicobacter Infections: new trials by email Literature Review of Helicobacter Infections trials Research Report on Helicobacter Infections
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Vonoprazan vs Proton Pump Inhibitor With Vitamin D or Probiotics Based Triple Therapy for Eradication of Helicobacter Pylori Infection Vonoparazan, Vitamin D, Probiotic - HELICOBACTER PYLORI INFECTIONS, Helicobacter Infection | Phase 2 | Recruiting | Tanta University | 132 | 2026-02-15 | 2026-09-09 |
| Study of Pylopass Versus Placebo in Subjects Who Are Helicobacter Pylori Carriers and With Mild Indigestion Pylopass, Placebo - HELICOBACTER INFECTION | Phase 2 / Phase 3 | Completed | Atlantia Food Clinical Trials | 24 | 2014-01-01 | 2015-01-15 |
| Safety and Efficacy Study of a Non-antibiotic Treatment for the Eradication of Helicobacter Pylori GT08 - Helicobacter Pylori Infection | Phase 1 / Phase 2 | Terminated | Synergy Pharmaceuticals Pte. Ltd. | 33 | 2010-05-01 | 2014-04-02 |
| Efficacy and Safety Study of Finafloxacin Used in Helicobacter Pylori Infected Patients Finafloxacin + Amoxicillin, Finafloxacin + Esomeprazole - Gram-Negative Bacterial Infections, Helicobacter Infections | Phase 2 | Completed | MerLion Pharmaceuticals GmbH | 30 | 2008-09-01 | 2009-06-16 |
| Second Line Therapy for the Cure of Helicobacter Pylori (H. Pylori) Infection rabeprazole, amoxicillin, clarithromycin, metronidazole - Helicobacter Infections, Gastritis | Phase 2 / Phase 3 | Unknown | Hamamatsu University | 2003-08-01 | 2006-03-21 | |
| Breath Ammonia Method for H. Pylori Detection: Phase II H. pylori treatment - Helicobacter Infections | Phase 2 | Completed | University of Washington | 278 | 2003-03-01 | 2008-01-11 |
Bacterial Infections (1) · Duodenal Ulcer (1) · Dyspepsia (1) · Gastritis (1) · Gram-Negative Bacterial Infections (1) · Stomach Ulcer (1)
Bacterial Infections and Mycoses (6) · Infections (6) · Bacterial Infections (5) · Gram-Negative Bacterial Infections (5) · Digestive System Diseases (1) · Duodenal Diseases (1) · Gastroenteritis (1) · Gastrointestinal Diseases (1) · Intestinal Diseases (1) · Pathological Conditions, Signs and Symptoms (1) · Peptic Ulcer (1) · Signs and Symptoms (1) · Signs and Symptoms, Digestive (1) · Stomach Diseases (1)
Amoxicillin (3) · Clarithromycin (2) · Esomeprazole (1) · Metronidazole (1) · Probiotics (1) · Proton Pump Inhibitors (1) · Rabeprazole (1) · Therapeutics (1) · Vitamin D (1) · finafloxacin (1)
Atlantia Food Clinical Trials (1) · Hamamatsu University (1) · MerLion Pharmaceuticals GmbH (1) · Synergy Pharmaceuticals Pte. Ltd. (1) · Tanta University (1) · University of Washington (1)
Egypt (1) · Germany (1) · Ireland (1) · Japan (1) · Singapore (1) · United States (1)
David L Putnam, PhD (1) · Ling Khoon Lin, MRCP, DPhil (1) · Martin JM Buckley, MRCPI, FRCPI (1) · Naohito Shirai, MD., PhD (1) · Peter Malfertheiner, MD, Director (1)
R44DK055935 (1)